Jakymiw A - Search Results

1

Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.

Alexander-Bryant AA, Dumitriu A, Attaway CC, Yu H, Jakymiw A. Alexander-Bryant AA, et al. Among authors: jakymiw a. J Control Release. 2015 Nov 28;218:72-81. doi: 10.1016/j.jconrel.2015.09.026. Epub 2015 Sep 18. J Control Release. 2015. PMID: 26386438 Free PMC article.

2

Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.

Cantini L, Attaway CC, Butler B, Andino LM, Sokolosky ML, Jakymiw A. Cantini L, et al. Among authors: jakymiw a. PLoS One. 2013 Sep 3;8(9):e73348. doi: 10.1371/journal.pone.0073348. eCollection 2013. PLoS One. 2013. PMID: 24019920 Free PMC article.

3

Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo.

Alexander-Bryant AA, Zhang H, Attaway CC, Pugh W, Eggart L, Sansevere RM, Andino LM, Dinh L, Cantini LP, Jakymiw A. Alexander-Bryant AA, et al. Among authors: jakymiw a. Oral Oncol. 2017 Sep;72:123-131. doi: 10.1016/j.oraloncology.2017.07.004. Epub 2017 Jul 21. Oral Oncol. 2017. PMID: 28797448 Free PMC article.

4

Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells.

Cantini LP, Andino LM, Attaway CC, Butler B, Dumitriu A, Blackshaw A, Jakymiw A. Cantini LP, et al. Among authors: jakymiw a. Mol Cancer. 2014 Aug 13;13:190. doi: 10.1186/1476-4598-13-190. Mol Cancer. 2014. PMID: 25115815 Free PMC article.

5

Peptide carriers to the rescue: overcoming the barriers to siRNA delivery for cancer treatment.

Cummings JC, Zhang H, Jakymiw A. Cummings JC, et al. Among authors: jakymiw a. Transl Res. 2019 Dec;214:92-104. doi: 10.1016/j.trsl.2019.07.010. Epub 2019 Jul 29. Transl Res. 2019. PMID: 31404520 Free PMC article. Review.

6

CIP2A expression and localization in oral carcinoma and dysplasia.

Katz J, Jakymiw A, Ducksworth MK, Stewart CM, Bhattacharyya I, Cha S, Chan EK. Katz J, et al. Among authors: jakymiw a. Cancer Biol Ther. 2010 Oct 1;10(7):694-9. doi: 10.4161/cbt.10.7.12895. Cancer Biol Ther. 2010. PMID: 21068540 Free PMC article.

7

Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing.

Holjencin CE, Feinberg CR, Hedrick T, Halsey G, Williams RD, Patel PV, Biles E, Cummings JC, Wagner C, Vyavahare N, Jakymiw A. Holjencin CE, et al. Among authors: jakymiw a. Mol Ther Nucleic Acids. 2021 Mar 19;24:462-476. doi: 10.1016/j.omtn.2021.03.013. eCollection 2021 Jun 4. Mol Ther Nucleic Acids. 2021. PMID: 33868789 Free PMC article.

8

MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention.

Holjencin C, Jakymiw A. Holjencin C, et al. Among authors: jakymiw a. Cells. 2022 Jul 29;11(15):2332. doi: 10.3390/cells11152332. Cells. 2022. PMID: 35954176 Free PMC article. Review.

9

Disruption of GW bodies impairs mammalian RNA interference.

Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, Hamel JC, Fritzler MJ, Chan EK. Jakymiw A, et al. Nat Cell Biol. 2005 Dec;7(12):1267-74. doi: 10.1038/ncb1334. Epub 2005 Nov 13. Nat Cell Biol. 2005. PMID: 16284622

10

The role of GW/P-bodies in RNA processing and silencing.

Jakymiw A, Pauley KM, Li S, Ikeda K, Lian S, Eystathioy T, Satoh M, Fritzler MJ, Chan EK. Jakymiw A, et al. J Cell Sci. 2007 Apr 15;120(Pt 8):1317-23. doi: 10.1242/jcs.03429. J Cell Sci. 2007. PMID: 17401112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page